Humoral Rejection After Kidney Transplantation

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-12-26
Clinical Trial Update: Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation [Phase 3]
A Phase 3 trial evaluating rituximab for progression of humoral acute rejection after kidney transplantation has completed.